Efficacy and Safety Study of Selinexor Combined with Dose-Adjusted Decitabine + CMG Regimen in Venetoclax-Exposed Patients with Relapsed/Refractory Acute Myeloid Leukemia (A Prospective, Multicenter, Single-Arm Study)

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: f0a75f6464e38548f95fabc840548b87bd8f2ddf
First added on: Jul 12, 2025